Insmed Inc. buy Wells Fargo & Company
Start price
03.09.25
/
50%
€124.00
Target price
03.09.26
€147.01
Performance (%)
-22.78%
Price
15.07.26
€96.38
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.78%. This prediction currently runs until 03.09.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -5.528% | -5.528% |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at Wells Fargo & Company from $140.00 to $171.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat